维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Vassina"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Immunopharmacological effects of topical tacrolimus in atopic dermatitis显示文摘	D. Simon E. Vassina L.R. Braathen H.U. Simon	2004	The Journal of Allergy and Clinical Immunology2004，，2：	1
	2	The 3348 M mutated form of cryopyrin is associated with defective lipopolysaccharide-induced interleukin 10 production in CINCA syndrome显示文摘	Bibl T Vassina E Boettger MK	2005	Ann Rheum Dis2005，64，9：	1
	3	Immunopharmacological effects of topical tacrolimus in atopic dermatitis显示文摘	Simon D Vassina E Braathen LR	2012	Journal of Allergy and Clinical Immunology2012，，02：	1
	4	Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis显示文摘	Vassina E Leverkus M Yousefi S	2005	J Invest Dermatol2005，125，4：	1
	5	cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis显示文摘	VASSINA E M YOUSEFI S SIMON D	2006	Eur J Immunol2006，36，7：	1
	6	Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment显示文摘	Simon D Vassina E Yousefi S	2005	Allergy2005，60，7：	1
	7	Immunopharmacological effects of topical tacrolimus in atopic dermatitis显示文摘	Simon D Vassina E Braathen LR	2004	J Allergy Clin Immunol2004，113，2：	1
	8	cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis 显示文摘	Vassina EM Yousefi S Simon D	2006	Eur J Immunol2006，36，：	1
	9	Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis显示文摘	VASSINA E LEVERKUS M YOUSEFI S	2005	J Invest Dermatol JT2005，125，4：	1
	10	特应性皮炎肿瘤坏死因子相关凋亡诱导配体(TRAIL)表达增强和潜在的抗炎作用显示文摘The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis of many transformed but also of non-transformed cells. In addition, TRAIL receptor activation has been reported to activate non-apoptotic signaling pathways. Here, we report an increased expression of TRAIL in peripheral blood T cells and monocytes from patients with atopic dermatitis (AD) compared with control individuals. High TRAIL expression was also observed in skin-infiltrating T cells of AD patients. Topical tacrolimus treatment reduced the total number of T cells in the skin, but the relative proportion of TRAIL-positive cells within both CD4+ and CD8+ cell populations did not change. TRAIL was demonstrated to induce the expression of interleukin-1 receptor antagonist (IL-1Ra) in keratinocytes in a caspase-independent manner in vitro. Moreover, increased expression of IL-1Ra was observed in keratinocytes of Ad lesional skin. These data suggest that TRAIL-expressing inflammatory skin cells may contribute to the epidermal activation of the IL-1Ra gene in AD.	Vassina E. LeverkusM. Yousefi S. D. Simon 任建文	2006	世界核心医学期刊文摘(皮肤病学分册)2006，2，8：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费